Abivax Shares Plunge After Company Reports Adverse Events in Key Drug Trial
RSS SUMMARY · AGGREGATED FROM TWSJ
The biotech said some patients developed cancer in a late-stage clinical trial for the bowel-disease drug that was unrelated to the treatment.
The biotech said some patients developed cancer in a late-stage clinical trial for the bowel-disease drug that was unrelated to the treatment.
The biotech said some patients developed cancer in a late-stage clinical trial for the bowel-disease drug that was unrelated to the treatment.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
Business
Eurozone Inflation Climbs Further, Paving Way for ECB Rate Hike
TWSJ·19m ago·3 min read
Business
Berkshire Hathaway’s $6.8 billion deal to acquire a major home builder reflects its conviction that the housing market will shake off its long slump and recover as it always has
TWSJ·47m ago·3 min read
Tech
Why ‘Nvidia Inside’ Can Work in the PC Market
TWSJ·47m ago·3 min read
Sports
The Shocking Trade That Sent the NFL’s Sack King to the Super Bowl Favorites
TWSJ·47m ago·3 min read
Related
On this beat
Health
Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
CNBC·2h ago·3 min read
Health
She got a $911,400 bill for treatment that was supposed to be free. The autism-therapy industry is booming—and so are the billing abuses.
TWSJ·9h ago·3 min read
Health
As Ebola Spreads, Scientists Race to Find Vaccines and Treatments
TNYT·9h ago·3 min read
Health
What makes promising pancreatic cancer drug different from chemotherapy?
CBS NEWS·10h ago·3 min read